Thursday, October 11, 2007

Key Marker For Colorectal Cancer Treatment, Interleukin-8, (Medical News Today)

Colorectal cancer (CRC) is currently one of the three most frequent malignancies in Western industrial nations. Although the 5-year survival rate for patients with early stage and local CRC approaches nearly 90%, survival is dramatically decreased by local recurrence and the development of distant metastases that primarily affect the liver, which are the predominant cause of CRC-related ...

Read More...

[Source: Yahoo! News Search Results for liver disease help]

No comments: